Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Hoffmann

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Communications Biology|January 18, 2022
Breaking the crosstalk of the Cellular Tumorigenic Network by low-dose combination therapy in lung cancer patient-derived xenograftsDennis Gürgen, Theresia Conrad, Michael Becker, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|October 16, 2008
Protein tyrosine phosphatase interacting protein 51 (PTPIP51) mRNA expression and localization and its in vitro interacting partner protein tyrosine phosphatase 1B (PTP1B) in human placenta of the first, second, and third trimesterAlbrecht Stenzinger, David Märker, Philipp Koch, et al.
Plos One|May 12, 2011
Molecular mode of action and role of TP53 in the sensitivity to the novel epothilone sagopilone (ZK-EPO) in A549 non-small cell lung cancer cellsSebastian Winsel, Anette Sommer, Julia Eschenbrenner, et al.
Cancer Gene Therapy|February 22, 2002
Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptorIris E Eder, Jens Hoffmann, Hermann Rogatsch, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|July 21, 2009
A posteriori registration and subtraction of panoramic compared with intraoral radiographyThomas M Deserno, Janaki Raman Rangarajan, Jens Hoffmann, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 2, 2010
In vitro characterization of ZK 230211--A type III progesterone receptor antagonist with enhanced antiproliferative propertiesWiebke Afhüppe, Johanna M Beekman, Christiane Otto, et al.
NMR in Biomedicine|April 9, 2015
Safety testing and operational procedures for self-developed radiofrequency coilsJens Hoffmann, Anke Henning, Ioannis A Giapitzakis, et al.
British Journal of Cancer|May 21, 2022
Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarkerFelicitas Schmid, Mathias Dahlmann, Hanna Röhrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkersIduna Fichtner, Jana Rolff, Richie Soong, et al.
Journal of Cancer Research and Clinical Oncology|February 11, 2018
Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomasTobias Kratzsch, Susanne Antje Kuhn, Andreas Joedicke, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Communications Biology|January 18, 2022
Breaking the crosstalk of the Cellular Tumorigenic Network by low-dose combination therapy in lung cancer patient-derived xenograftsDennis Gürgen, Theresia Conrad, Michael Becker, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|October 16, 2008
Protein tyrosine phosphatase interacting protein 51 (PTPIP51) mRNA expression and localization and its in vitro interacting partner protein tyrosine phosphatase 1B (PTP1B) in human placenta of the first, second, and third trimesterAlbrecht Stenzinger, David Märker, Philipp Koch, et al.
Plos One|May 12, 2011
Molecular mode of action and role of TP53 in the sensitivity to the novel epothilone sagopilone (ZK-EPO) in A549 non-small cell lung cancer cellsSebastian Winsel, Anette Sommer, Julia Eschenbrenner, et al.
Cancer Gene Therapy|February 22, 2002
Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptorIris E Eder, Jens Hoffmann, Hermann Rogatsch, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|July 21, 2009
A posteriori registration and subtraction of panoramic compared with intraoral radiographyThomas M Deserno, Janaki Raman Rangarajan, Jens Hoffmann, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 2, 2010
In vitro characterization of ZK 230211--A type III progesterone receptor antagonist with enhanced antiproliferative propertiesWiebke Afhüppe, Johanna M Beekman, Christiane Otto, et al.
NMR in Biomedicine|April 9, 2015
Safety testing and operational procedures for self-developed radiofrequency coilsJens Hoffmann, Anke Henning, Ioannis A Giapitzakis, et al.
British Journal of Cancer|May 21, 2022
Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarkerFelicitas Schmid, Mathias Dahlmann, Hanna Röhrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkersIduna Fichtner, Jana Rolff, Richie Soong, et al.
Journal of Cancer Research and Clinical Oncology|February 11, 2018
Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomasTobias Kratzsch, Susanne Antje Kuhn, Andreas Joedicke, et al.
Pageof 9